NCT01111656.

Methods	Randomized single blinded parallel‐group‐study
Participants	28 patients with Relapsing‐Remitting MS (according to McDonald's criteria) Successful completion of the SWABIMS study
Interventions	Intervention group: interferon beta‐1b and atorvastatin 40 mg Control group: interferon beta‐1b
Outcomes	Primary outcomes: proportion of patients with new lesions on T2‐weighted images after 12 months of treatment. Secondary Outcomes: Gd‐enhancing lesions on T1‐weighted images, change of total T2 lesion volume, cortical atrophy, clinical disease progression, number of relapse free patients, relapse rate, and time to first relapse.
Notes	Sponsored by University Hospital Inselspital, Berne. http://clinicaltrials.gov/ct2/show/NCT01111656